Page last updated: 2024-10-26

dipyridamole and Apnea

dipyridamole has been researched along with Apnea in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Apnea: A transient absence of spontaneous respiration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ottervanger, JP1
Haan, D1
Gans, SJ1
Hoorntje, JC1
Stricker, BH1

Other Studies

1 other study available for dipyridamole and Apnea

ArticleYear
[Bronchospasm, apnea and heart arrest following dipyridamole perfusion scintigraphy].
    Nederlands tijdschrift voor geneeskunde, 1993, Jan-16, Volume: 137, Issue:3

    Topics: Aged; Apnea; Bronchial Spasm; Dipyridamole; Heart Arrest; Humans; Lung Diseases, Obstructive; Male

1993